[13 May 2013]
Products Affected - Description
100 mg vial (NDC 00409-4856-05)
Reason for the Shortage
- Hospira has A-Hydrocort on shortage due to capacity constraints.
- Pfizer changed their NDC numbers for the Solu-Cortef Act-O-Vials in mid-2012.
100 mg plain vial (NDC 00009-0825-01)
100 mg/2 mL, preservative-free Act-O-Vial, 1 count (NDC 00009-0011-03)
100 mg/2 mL, preservative-free Act-O-Vial, 25 count (NDC 00009-0011-04)
100 mg/2 mL, Act-O-Vial, 1 count (NDC 00009-0900-13)
100 mg/2 mL, Act-O-Vial, 25 count (NDC 00009-0900-20)
250 mg/2 mL, preservative-free Act-O-Vial, 1 count (NDC 00009-0013-05)
250 mg/2 mL, preservative-free Act-O-Vial, 25 count (NDC 00009-0013-06)
250 mg/2 mL, Act-O-Vial, 1 count (NDC 00009-0909-08)
250 mg/2 mL, Act-O-Vial, 25 count (NDC 00009-0909-16)
500 mg, preservative-free Act-O-Vial (NDC 00009-0016-12)
500 mg, Act-O-Vial (NDC 00009-0912-05)
1000 mg, preservative-free Act-O-Vial (NDC 00009-0005-01)
1000 mg, Act-O-Vial (NDC 00009-0920-03)
Estimated Resupply Dates
Hospira has A-Hydrocort 100 mg vials on back order with an estimated release date in 2013.
May 13, 2013; February 28, 2013; November 29, 2012; August 17, 2012; June 19, 2012; May 30, 2012; May 24, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins